These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29698727)

  • 41. Measuring the specific surface area (SSA) of freeze-dried biologics using inverse gas chromatography.
    Duralliu A; Matejtschuk P; Williams DR
    Eur J Pharm Biopharm; 2019 Sep; 142():216-221. PubMed ID: 31233863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of annealing on the physical properties of therapeutic proteins during freeze drying process.
    Lim JY; Lim DG; Kim KH; Park SK; Jeong SH
    Int J Biol Macromol; 2018 Feb; 107(Pt A):730-740. PubMed ID: 28939511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization.
    Cao W; Xie Y; Krishnan S; Lin H; Ricci M
    Pharm Res; 2013 Jan; 30(1):131-9. PubMed ID: 22907420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased protein-stabilizing effects of cryoprotectants due to crystallization.
    Izutsu K; Yoshioka S; Terao T
    Pharm Res; 1993 Aug; 10(8):1232-7. PubMed ID: 8415413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.
    Kim AI; Akers MJ; Nail SL
    J Pharm Sci; 1998 Aug; 87(8):931-5. PubMed ID: 9687336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
    Horn J; Schanda J; Friess W
    Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring the chemical space for freeze-drying excipients.
    Meng-Lund H; Holm TP; Poso A; Jorgensen L; Rantanen J; Grohganz H
    Int J Pharm; 2019 Jul; 566():254-263. PubMed ID: 31145963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preserving enhancement in freeze-dried contrast agent ST68: Examination of excipients.
    Solis C; Forsberg F; Wheatley MA
    Int J Pharm; 2010 Aug; 396(1-2):30-8. PubMed ID: 20540998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
    Lueckel B; Bodmer D; Helk B; Leuenberger H
    Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using Texture Analysis Technique to Assess the Freeze-Dried Cakes in Vials.
    Hackl EV; Ermolina I
    J Pharm Sci; 2016 Jul; 105(7):2073-85. PubMed ID: 27290623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
    Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
    Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
    Naini V; Byron PR; Phillips EM
    Drug Dev Ind Pharm; 1998 Oct; 24(10):895-909. PubMed ID: 9876544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of temperature on water vapor sorption by some amorphous pharmaceutical sugars.
    Hancock BC; Dalton CR
    Pharm Dev Technol; 1999 Jan; 4(1):125-31. PubMed ID: 10027221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In situ precipitation and vacuum drying of interferon alpha-2a: development of a single-step process for obtaining dry, stable protein formulation.
    Kumar V; Sharma VK; Kalonia DS
    Int J Pharm; 2009 Jan; 366(1-2):88-98. PubMed ID: 18824225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
    Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Moisture-dependent crystallization of amorphous lamotrigine mesylate.
    Schmitt E; Davis CW; Long ST
    J Pharm Sci; 1996 Nov; 85(11):1215-9. PubMed ID: 8923328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Through-vial impedance spectroscopy of critical events during the freezing stage of the lyophilization cycle: the example of the impact of sucrose on the crystallization of mannitol.
    Arshad MS; Smith G; Polygalov E; Ermolina I
    Eur J Pharm Biopharm; 2014 Aug; 87(3):598-605. PubMed ID: 24825125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of water plasticization on the molecular mobility and crystallization tendency of amorphous disaccharides.
    Heljo VP; Nordberg A; Tenho M; Virtanen T; Jouppila K; Salonen J; Maunu SL; Juppo AM
    Pharm Res; 2012 Oct; 29(10):2684-97. PubMed ID: 22203327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlling the physical form of mannitol in freeze-dried systems.
    Mehta M; Bhardwaj SP; Suryanarayanan R
    Eur J Pharm Biopharm; 2013 Oct; 85(2):207-13. PubMed ID: 23643784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of co-solutes and process variables on crystallinity and the crystal form of freeze-dried myo-inositol.
    Izutsu KI; Kusano R; Arai R; Yoshida H; Ito M; Shibata H; Sugano K; Goda Y; Terada K
    Int J Pharm; 2016 Jul; 509(1-2):368-374. PubMed ID: 27282535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.